Thyroid function tests: Performance and limitations of current methodologies

References

• Hay I D, Bayer M F, Kaplan M M, Klee G G, Larsen P R, Spencer C A. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 1991; 37: 2002–8
   PubMed Web of Science ®Google Scholar
• Lindstedt G. Medical needs in the evaluation of thyroid dysfunction. Uppsala J Med Sci 1990; 95: 197–211
   PubMed Web of Science ®Google Scholar
• Weeke J, Boye N, Örskov H. Ultrafiltration method for direct radioimmunoassay measurement of free thyroxine and free triiodothyronine in serum. Scand J Clin Lab Invest 1986; 46: 381–9
   PubMed Web of Science ®Google Scholar
• Tikanoja S H, Liewendahl B K. New ultrafiltration method for free thyroxin compared with equilibrium dialysis in patients with thyroid dysfunction and non-thyroidal illness. Clin Chem 1990; 36: 800–4
   PubMed Web of Science ®Google Scholar
• Helenius T, Liewendahl K. Improved dialysis method for free thyroxin in scrum compared with five commercial radio-immunoassays in nonthyroidal illness and subjects with abnormal concentrations of thyroxin-binding globulin. Clin Chem 1983; 29: 816–22
   PubMed Web of Science ®Google Scholar
• Nelson J C, Tomei R T. Direct determination of free thyroxin in undiluted serum by equilibrium dialysis/radioimmunoassay. Clin Chem 1988; 34: 1737–44
   PubMed Web of Science ®Google Scholar
• Ekins R. Measurement of free hormones in blood. Endocr Rev 1990; ii: 5–46
   Google Scholar
• Wilcox R B, Nelson J C. Time course of pH regulation in free thyroxin determinations in serum (Letter). Clin Chem 1991; 37: 1298–9
   PubMed Web of Science ®Google Scholar
• Liewendahl B K, Tikanoja S H. Time course of pH regulation in free thyroxin determinations in serum (Response). Clin Chem 1991; 37: 1299–1300
   Web of Science ®Google Scholar
• Robbins J, Rall J E. The iodine-containing hormones. Hormones and blood I, vol 3, 3rd ed., CH Gray, VHT James. Academic Press, London 1979; 575–688
   Google Scholar
• Blomberg K R, Engblom S O. Mathematical theory of complex ligand-binding systems applied to free triiodothyronine immunoassays. Anal Chem 1991; 63: 2581–6
   PubMed Web of Science ®Google Scholar
• Pettersson T M. Studies of thyroxine binding globulin and transthyretin (pre-albumin) with special reference to their significance for free thyroxine concentration. Karolinska Institute, Stockholm 1989; 1–86, Dissertation Thesis, Repro Print
   Google Scholar
• Christofides N D, Sheehan C P, Midgley J EM. One-step labelled-antibody assay for measuring free thyroxin. I. Assay development and validation. Clin Chem 1992; 38: 11–8
   PubMedGoogle Scholar
• Beckett G J, Ratcliffe W A, Chapman B M, Wu P, Rae P WH, Gow S M, Toft A D. Non-isotopic two-step free thyroxine immunoassay: a better measure of free thyroxine than analogue radioimmunoassay. Ann Clin Biochem 1990; 27: 581–91
   PubMed Web of Science ®Google Scholar
• Wallace A M, Aitkin S, Duffy F A, Fraser W D, Beastall G H. Measuring free thyroxin by using magnetic antibody-containing microcapsules. Clin Chem 1990; 36: 614–9
   PubMed Web of Science ®Google Scholar
• Beaman J, Woodhead J S, Liewendahl K, Mähönen H. The evaluation of a chemiluminescent assay for free thyroxine by comparison with equilibrium dialysis in clinical samples. Clin Chim Acta 1989; 186: 83–90
   PubMed Web of Science ®Google Scholar
• Ooi D S, Mahadevan M S, Greenway D C, Gertier S Z. Evaluation of four commercially available assays for free thyroxin. Clin Chem 1988; 34: 2302–7
   PubMed Web of Science ®Google Scholar
• Nuutila P, Koskinen P, Irjala K, Linko L, Kaihola H-L, Eskola J U, Erkkola R, Seppälä P, Viikari J. Two new two-step immunoassays for free thyroxin evaluated: solid-phase radioimmunoassay and time-resolved fluoroimmunoassay. Clin Chem 1990; 36: 1355–60
   PubMed Web of Science ®Google Scholar
• Liewendahl K. Assessment of thyroid status by laboratory methods: developments and perspectives. Scand J Clin Lab Invest 1990; 50: 83–92, (suppl 201)
   Web of Science ®Google Scholar
• Ross D S, Ardisson L J, Meskell M J. Measurement of thyrotropin in clinical and subclinical hyperparathyroidism using a new chemiluminescent assay. J Clin Endocrinol Metab 1989; 69: 684–8
   PubMed Web of Science ®Google Scholar
• Spencer C A, Lopresti J S, Patel A, Guttler R B, Eigen A, Shen D, Gray D, Nicoloff J T. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab 1990; 70: 453–60
   PubMed Web of Science ®Google Scholar
• Faber J, Gam A, Siersbaek-Nielsen K. Improved sensitivity of scrum thyrotropin measurements. Studies on serum sex hormone-binding globulin in patients with reduced scrum thyrotropin. Acta Endocrinol (Copenh) 1990; 123: 535–40
   PubMedGoogle Scholar
• Browning M CK, Ford R P, Callaghan S J, Fraser C G. Intra-and interindividual biological variation of five analytes used in assessing thyroid function: implications for necessary standards of performance and the interpretation of results. Clin Chem 1986; 32: 962–6
   PubMed Web of Science ®Google Scholar
• Juan-Pereira L, Navarro M A, Roca M, Fuentes-Arderiu X. Within-subject variation of thyroxin and triiodothyronine concentrations in serum (Letter). Clin Chem 1991; 37: 772–3
   PubMed Web of Science ®Google Scholar
• John R, Henley R, Shankland D. Concentrations of free thyroxin and free triiodothyronine in serum of patients with thyroxin-and triiodothyronine-binding autoantibodies. Clin Chem 1990; 36: 470–3
   PubMed Web of Science ®Google Scholar
• Benvenga S, Trimarchi F, Robbins J. Circulating thyroid hormone autoantibodies (Review article). J Endocrinol Invest 1987; 10: 605–19
   PubMed Web of Science ®Google Scholar
• John R, Othman S, Parkes A B, Lazarus J H, Hall R. Interference in thyroid-function tests in postpartum thyroiditis. Clin Chem 1991; 37: 1397–1400
   PubMed Web of Science ®Google Scholar
• Stockigt J R, Dyer S A, Mohr V S, White E L, Barlow J W. Specific methods to identify plasma binding abnormalities in euthyroid hyperthyroxinemia. J Clin Endocrinol Metab 1986; 62: 230–3
   PubMed Web of Science ®Google Scholar
• Boscato L M, Stuart M C. Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32: 1491–5
   PubMed Web of Science ®Google Scholar
• John R, Henley R, Barron N. Antibody interference in two-site immunometric assay for thyrotropin. Ann Clin Biochem 1989; 26: 346–52
   PubMed Web of Science ®Google Scholar
• Weber T H, Käpyaho KI, Tanner P. Endogenous interference in immunoassays in clinical chemistry (A review). Scand J Clin Lab Invest 1990; 50: 77–82, (suppl 201)
   PubMed Web of Science ®Google Scholar
• Arevalo G. Binding of labelled thyroxin analog to serum proteins evaluated alter radioimmunoassay of free thyroxin. Clin Chem 1989; 35: 475–7
   PubMed Web of Science ®Google Scholar
• Moses A C, Rosen H N, Moller D E, Tsuzaki S, Haddow J E, Lawlor J, Liepnicks J J, Nichols W C, Benson M D. A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J Clin Invest 1990; 86: 2025–33
   PubMed Web of Science ®Google Scholar
• Martino E, Pacchiarotti A, Aghini-Lomhardi F, Grasso L, Bambini G, Baschieri L, Pinchera A. Serum free thyroxine in patients with T3-toxicosis. Acta Endocrinol (Copenh) 1985; 110: 354–9
   PubMedGoogle Scholar
• Liewendahl K, Tikanoja S, Helenius T, Vällimäki M. Discrepancies between serum free triiodothyronine and free thyroxin as measured by equilibrium dialysis and analog radioimmunoassay in nonthyroidal illnesses. Clin Chem 1984; 30: 760–2
   PubMed Web of Science ®Google Scholar
• Chopra I J, Huang T-S, Berado A, Solomon D H, Chua Teco G N. Serum thyroid hormone binding inhibitor in nonthyroidal illnesses. Metabolism 1986; 35: 152–9
   PubMed Web of Science ®Google Scholar
• John R, Evans P E, Scanlon M F, Hall R. Clinical value of immunoradiometric assay of thryotropin for patients with nonthyroidal illness and taking various drugs. Clin Chem 1987; 33: 567–9
   Web of Science ®Google Scholar
• Liewendahl K, Tikanoja S, Mähönen H, Helenius T, Välimäki M, Tallgren L G. Concentrations of iodothyronines in serum of patients with chronic renal failure and other nonthyroidal illnesses: role of free fatty acids. Clin Chem 1987; 33: 1382–6
   PubMed Web of Science ®Google Scholar
• Spencer C, Eigen A, Shen D, Duda M, Quails S, Weiss S, Nicoloff J. Specificity of sensitive assays of thyrotropin (TSH) used to screen lor thyroid disease in hospitalized patients. Clin Chem 1987; 33: 1391–6
   PubMed Web of Science ®Google Scholar
• Faber J, Kierkegaard C, Rasmussen B, Westh H, Busch-Sörcnsen H, Jensen I W. Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987; 65: 315–20
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Mähönen H, Tikanoja S, Helenius T, Turula M, Välimäki M. Performance of direct equilibrium dialysis and analogue-type free thyroid hormone assays and an immunoradiometric TSH method in patients with thyroid dysfunction. Scand J Clin Lab Invest 1987; 47: 421–8
   PubMed Web of Science ®Google Scholar
• Mills G H, Ellis R D, Beck P R. Exaggerated and prolonged thyrotropin releasing hormone (TRH) test responses in tertiary hypothyroidism. J Clin Pathol 1991; 44: 522–3
   PubMed Web of Science ®Google Scholar
• Välimäki M, Liewendahl K, Karonen S-L, Helenius T, Suikkari A-M. Concentrations of somatomedin-C and triiodothyronine in patients with thyroid dysfunction and nonthyroidal illnesses. J Endocrinol Invest 1990; 13: 155–9
   PubMed Web of Science ®Google Scholar
• Beckett G J, Wilkinson E, Rae P W, Gow S, Wu PS-C, Toft A D. The clinical utility of a non-isotopic two-step assay (DELFIA) and an analogue radioimmunoassay (SimulTRAC) for free thyroxine compared. Ann Clin Biochem 1991; 28: 335–44
   PubMed Web of Science ®Google Scholar
• Välimäki M, Liewendahl K, Nikkanen P, Pelkonen R. Hormonal changes in severely uncontrolled type I (insulin-dependent) diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 385–93
   PubMed Web of Science ®Google Scholar
• Nelson J C, Weiss R M. The effect of dilution on free thyroxine (T4) concentration in the low T4 syndrome of nonthyroidal illness. J Clin Endocrinol Metab 1985; 61: 239–46
   PubMed Web of Science ®Google Scholar
• Mendel C M, Laughton C W, McMahon F A, Cavalieri R R. Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with non-thyroid illness. Metabolism 1991; 40: 491–502
   PubMed Web of Science ®Google Scholar
• Bregengård C, Kirkegaard C, Faher J, Poulsen S, Siershaek-Nielsen K, Friis T. The influence of free fatty acids on the free fraction of thyroid hormones in serum as estimated by ultrafiltration. Acta Endocrinol (Copenh) 1987; 116: 102–7
   PubMedGoogle Scholar
• Tikanoja S H, Joutti A, Liewendahl B K. Association between increased concentrations of free thyroxine and unsaturated free fatty acids in non-thyroidal illnesses: role of albumin. Clin Chim Acta 1989; 179: 33–44
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Helenius T, Näveri H, Tikkanen H. Fatty acid-induced increase in serum dialyzable free thyroxine after physical exercise: implication for non-thyroidal illness. J Clin Endocrinol Metab 1992; 74: 1361–5
   PubMed Web of Science ®Google Scholar
• Lim C-F, Curtis A J, Barlow J W, Topliss D J, Stockigt J R. Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serum. J Clin Endocrinol Metab 1991; 73: 1106–10
   PubMed Web of Science ®Google Scholar
• Chopra I J, Sakanc S, Chua Teco G N. A study of the scrum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab 1991; 72: 1113–6
   PubMed Web of Science ®Google Scholar
• Poll van der T, Romijn J A, Wiersinga W M, Sauerwin H P. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71: 1567–72
   PubMed Web of Science ®Google Scholar
• Williams G R, Neuberger J M, Franklyn J A, Sheppard M C. Thyroid hormone receptor expression in the ‘sick euthyroid’ syndrome. Lancet 1989; ii: 1477–81
   Google Scholar
• Klis van der FRM, Schmidt E DL, van Beeren HC, Wiersinga W M. Competitive inhibition of T3 binding to α1 and β1 thyroid hormone receptors by fatty acids. Biochem Biophys Res Commun 1991; 179: 1011–6
   PubMed Web of Science ®Google Scholar
• Csako G, Zweig M H, Benson C, Ruddel M. On the albumin-dependence of measurements of free thyroxin. II. Patients with non-thyroidal illness. Clin Chem 1987; 33: 87–92
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Tikanoja S, Helenius T, Mähönen H. Serum FT4 and FT3: Modified analog assays compared with dialysis method in thyroid dysfunction (Tech Brief). Clin Chem 1987; 33: 716–7
   PubMed Web of Science ®Google Scholar
• Witherspoon L R, El Shami A S, Shuler S E, Neely H, Sonnemaker R, Gilbert S S. Chemically blocked analog assays of free thyroxines. I. The effect of chemical blockers on T4 analog and T4 binding by albumin and by thyroxin-binding globulin. Clin Chem 1988; 34: 9–16
   PubMed Web of Science ®Google Scholar
• Wang Y-S, Hershman J M, Smith V, Pckary A E. Effect of heparin on free thyroxin as measured by equilibrium and ultrafiltration (Tech Brief). Clin Chem 1986; 32: 700
   PubMed Web of Science ®Google Scholar
• Lundberg P-A, Jagenburg R, Lindstedt G, Nyström E. Heparin in vivo effect on free thyroxin (Letter). Clin Chem 1982; 28: 1241–2
   PubMed Web of Science ®Google Scholar
• Rootwelt K, Ganes T, Johannessen S I. Effect of carbamazepine phenytoin and phenobarbitonc on serum levels of thyroid hormones and thyrotropin in humans. Scand J Clin Lab Invest 1978; 38: 731–6
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Tikanoja S, Helenius T, Majuri H. Free thyroxin and free triiodothyronine as measured by equilibrium dialysis and analog rudioimmunoassay in serum of patients taking phenytoin and carbamazepine. Clin Chem 1985; 31: 1993–6
   PubMed Web of Science ®Google Scholar
• Curran P G, DeGroot L J. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991; 12: 135–50
   PubMed Web of Science ®Google Scholar
• Wenzel K W. Pharmacological interference with in vitro tests of thyroid function. Metabolism 1981; 30: 717–32
   PubMed Web of Science ®Google Scholar
• Cooper D S. Substances that affect thyroid function or thyroid hormone metabolism. The thyroid gland. 2nd ed., MA Grcer. Raven Press, New York 1990; 323–44
   Google Scholar
• Bernal J, Liewendahl K, Lamberg B-A. Thyroid hormone receptors in fetal and hormone resistant tissues (Editorial review). Scand J Clin Lab Invest 1985; 45: 577–83
   PubMed Web of Science ®Google Scholar
• Takeda K, Sakurai A, DeGroot L J, Refetoff S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-β gene. J Clin Endocrinol Metab 1992; 74: 49–55
   PubMed Web of Science ®Google Scholar
• Liewendahl K, Helenius T, Lumberg B-A, Mähönen H, Wägar G. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy. Acta Endocrinol (Copenh) 1987; 116: 418–24
   PubMedGoogle Scholar
• White G H. Recent advances in routine thyroid function testing. CRC Crit Rev Clin Lab Sci 1987; 24: 315–62
   Google Scholar